| Year |
Citation |
Score |
| 2020 |
Delaney JR, Patel CB, Bapat J, Jones CM, Ramos-Zapatero M, Ortell KK, Tanios R, Haghighiabyaneh M, Axelrod J, DeStefano JW, Tancioni I, Schlaepfer DD, Harismendy O, La Spada AR, Stupack DG. Autophagy gene haploinsufficiency drives chromosome instability, increases migration, and promotes early ovarian tumors. Plos Genetics. 16: e1008558. PMID 31923184 DOI: 10.1371/Journal.Pgen.1008558 |
0.396 |
|
| 2020 |
Dempsey A, Yau C, Harismendy O, Donnenfield J, Basu A, Campbell M, Borowsky AD, Hirst G, Esserman LJ. Abstract P6-06-07: Gene expression changes in the epithelium and stroma of invasive ductal carcinoma and ductal carcinoma in situ: A meta-analysis Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-06-07 |
0.343 |
|
| 2020 |
O'Keefe T, Yau C, Jeong E, Iaconetti E, Kim P, Griffin A, McGuire J, Mukhtar R, Esserman L, Harismendy O, Hirst GL. Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-08-05 |
0.304 |
|
| 2020 |
O'Keefe T, Blair S, Hosseini A, Harismendy O, Wallace A. Abstract 6461: HER2 positive DCIS increases short term risk of ipsilateral invasive ductal carcinoma in breast conserving surgery patients Endocrinology. 80: 6461-6461. DOI: 10.1158/1538-7445.Am2020-6461 |
0.316 |
|
| 2020 |
Sun Q, Wang Y, Officer A, Harismendy O, Desgrosellier JS. Abstract 6024: An integrin αvβ3+ stem-like tumor cell subset promotes breast cancer progression via c-Jun/AXL signaling Cancer Research. 80: 6024-6024. DOI: 10.1158/1538-7445.Am2020-6024 |
0.37 |
|
| 2020 |
Glencer A, Harismendy O, Borowsky A, Hirst GL, Stein J, Evans M, Weaver D, West R, Brabham C, Mori H, Esserman LJ. Abstract 5440: Understanding the biology of high-risk ductal carcinoma in situ (DCIS) through genomics and the tumor immune microenvironment: The DEFENSE study Cancer Research. 80: 5440-5440. DOI: 10.1158/1538-7445.Am2020-5440 |
0.396 |
|
| 2019 |
Wu V, Yeerna H, Nohata N, Chiou J, Harismendy O, Raimondi F, Inoue A, Russell RB, Tamayo P, Gutkind JS. Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy. The Journal of Biological Chemistry. PMID 31171722 DOI: 10.1074/Jbc.Rev119.005601 |
0.342 |
|
| 2019 |
Ghia EM, Rassenti LZ, Neuberg DS, Blanco A, Yousif F, Smith EN, McPherson JD, Hudson TJ, Harismendy O, Frazer KA, Kipps TJ. Activation of Hedgehog signaling associates with early disease progression in chronic lymphocytic leukemia. Blood. PMID 30923040 DOI: 10.1182/Blood-2018-09-873695 |
0.358 |
|
| 2019 |
Harismendy O, Kim J, Xu X, Ohno-Machado L. Evaluating and sharing global genetic ancestry in biomedical datasets. Journal of the American Medical Informatics Association : Jamia. PMID 30869786 DOI: 10.1093/Jamia/Ocy194 |
0.301 |
|
| 2018 |
Sagredo EA, Blanco A, Sagredo AI, Pérez P, Sepúlveda-Hermosilla G, Morales F, Müller B, Verdugo R, Marcelain K, Harismendy O, Armisén R. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biological Research. 51: 36. PMID 30290838 DOI: 10.1186/S40659-018-0185-4 |
0.305 |
|
| 2018 |
Dow M, Pyke RM, Tsui BY, Alexandrov LB, Nakagawa H, Taniguchi K, Seki E, Harismendy O, Shalapour S, Karin M, Carter H, Font-Burgada J. Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30287485 DOI: 10.1073/Pnas.1811029115 |
0.35 |
|
| 2018 |
Alattar AA, Carroll KT, Bryant AK, Hirshman B, Joshi R, Carter BS, Harismendy O, Chen CC. Prognostic importance of age, tumor location, and tumor grade in grade II astrocytomas: an integrated analysis of The Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results database. World Neurosurgery. PMID 30266697 DOI: 10.1016/J.Wneu.2018.09.124 |
0.332 |
|
| 2018 |
Buckley AR, Ideker T, Carter H, Harismendy O, Schork NJ. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Medicine. 10: 69. PMID 30217226 DOI: 10.1186/S13073-018-0579-5 |
0.411 |
|
| 2018 |
Zhou Y, Xu Z, Quan D, Zhang F, Zhang H, Xiao T, Hou S, Qiao H, Harismendy O, Wang JYJ, Suo G. Nuclear respiratory factor 1 promotes spheroid survival and mesenchymal transition in mammary epithelial cells. Oncogene. PMID 29995872 DOI: 10.1038/S41388-018-0349-2 |
0.333 |
|
| 2018 |
Carroll KT, Bryant AK, Hirshman B, Alattar AA, Joshi R, Gabel B, Carter BS, Harismendy O, Vaida F, Chen CC. Interaction between the contributions of tumor location, tumor grade, and patient age to the survival benefit associated with gross total resection (GTR). World Neurosurgery. PMID 29309983 DOI: 10.1016/J.Wneu.2017.12.165 |
0.308 |
|
| 2018 |
Shen JP, Jacobs MT, Fuh IL, Baumgartner JM, Fanta PT, Lowy AM, Harismendy O. Somatic mutation landscape of appendiceal cancer. Journal of Clinical Oncology. 36: 671-671. DOI: 10.1200/Jco.2018.36.4_Suppl.671 |
0.372 |
|
| 2018 |
Champa D, Sun S, Tsai C, Howell S, Harismendy O. Abstract 2860A: Evolution and characterization of carboplatin resistance at single-cell resolution Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-2860A |
0.312 |
|
| 2017 |
Spahn PN, Bath T, Weiss RJ, Kim J, Esko JD, Lewis NE, Harismendy O. PinAPL-Py: A comprehensive web-application for the analysis of CRISPR/Cas9 screens. Scientific Reports. 7: 15854. PMID 29158538 DOI: 10.1038/S41598-017-16193-9 |
0.308 |
|
| 2017 |
Bannon AE, Kent JD, Forquer I, Town A, Klug LR, McCann KE, Beadling C, Harismendy O, Sicklick JK, Corless CL, Shinde U, Heinrich MC. Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28724664 DOI: 10.1158/1078-0432.Ccr-17-1397 |
0.363 |
|
| 2017 |
Buckley AR, Standish KA, Bhutani K, Ideker T, Lasken RS, Carter H, Harismendy O, Schork NJ. Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls. Bmc Genomics. 18: 458. PMID 28606096 DOI: 10.1186/S12864-017-3770-Y |
0.362 |
|
| 2017 |
Panopoulos AD, D'Antonio M, Benaglio P, Williams R, Hashem SI, Schuldt BM, DeBoever C, Arias AD, Garcia M, Nelson BC, Harismendy O, Jakubosky DA, Donovan MKR, Greenwald WW, Farnam K, et al. iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types. Stem Cell Reports. 8: 1086-1100. PMID 28410642 DOI: 10.1016/J.Stemcr.2017.03.012 |
0.344 |
|
| 2017 |
Delaney JR, Patel CB, Willis KM, Haghighiabyaneh M, Axelrod J, Tancioni I, Lu D, Bapat J, Young S, Cadassou O, Bartakova A, Sheth P, Haft C, Hui S, Saenz C, ... ... Harismendy O, et al. Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer. Nature Communications. 8: 14423. PMID 28198375 DOI: 10.1038/Ncomms14423 |
0.367 |
|
| 2017 |
Kim J, Shimizu C, Kingsmore SF, Veeraraghavan N, Levy E, Ribeiro Dos Santos AM, Yang H, Flatley J, Hoang LT, Hibberd ML, Tremoulet AH, Harismendy O, Ohno-Machado L, Burns JC. Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility. Plos One. 12: e0170977. PMID 28151979 DOI: 10.1371/Journal.Pone.0170977 |
0.328 |
|
| 2016 |
Shi E, Chmielecki J, Tang CM, Wang K, Heinrich MC, Kang G, Corless CL, Hong D, Fero KE, Murphy JD, Fanta PT, Ali SM, De Siena M, Burgoyne AM, Movva S, ... ... Harismendy O, et al. FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors. Journal of Translational Medicine. 14: 339. PMID 27974047 DOI: 10.1186/S12967-016-1075-6 |
0.353 |
|
| 2016 |
Tang CM, Lee TE, Syed SA, Burgoyne AM, Leonard SY, Gao F, Chan JC, Shi E, Chmielecki J, Morosini D, Wang K, Ross JS, Kendrick ML, Bardsley MR, De Siena M, ... ... Harismendy O, et al. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression. Oncotarget. PMID 27793025 DOI: 10.18632/Oncotarget.12909 |
0.394 |
|
| 2016 |
Levy E, Marty R, Gárate Calderón V, Woo B, Dow M, Armisen R, Carter H, Harismendy O. Immune DNA signature of T-cell infiltration in breast tumor exomes. Scientific Reports. 6: 30064. PMID 27452728 DOI: 10.1038/Srep30064 |
0.4 |
|
| 2016 |
Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Patel SP, Harismendy O, Ikeda M, Parker BA, Kurzrock R. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27185373 DOI: 10.1158/1078-0432.Ccr-16-0318 |
0.313 |
|
| 2016 |
Harismendy O, Levy ED, Garate-Calderon V, Woo B, Armisen R. Abstract 847: Molecular characterization of breast tumor T-cell infiltration in exome datasets Cancer Research. 76: 847-847. DOI: 10.1158/1538-7445.Am2016-847 |
0.407 |
|
| 2015 |
Bao L, Messer K, Schwab R, Harismendy O, Pu M, Crain B, Yost S, Frazer KA, Rana B, Hasteh F, Wallace A, Parker BA. Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors. Plos One. 10: e0142487. PMID 26554380 DOI: 10.1371/Journal.Pone.0142487 |
0.359 |
|
| 2015 |
Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon CH, et al. Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression. Proceedings of the National Academy of Sciences of the United States of America. 112: E4055-64. PMID 26159421 DOI: 10.1073/Pnas.1501967112 |
0.328 |
|
| 2015 |
Smith EN, Ghia EM, DeBoever CM, Rassenti LZ, Jepsen K, Yoon KA, Matsui H, Rozenzhak S, Alakus H, Shepard PJ, Dai Y, Khosroheidari M, Bina M, Gunderson KL, Messer K, ... ... Harismendy O, et al. Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development. Blood Cancer Journal. 5: e303. PMID 25860294 DOI: 10.1038/Bcj.2015.14 |
0.314 |
|
| 2015 |
Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, et al. Abstract PR02: Dynamic epigenetic regulation of glioblastoma tumorigenicity through a LSD1-MYC-OLIG2 axis Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-Pr02 |
0.348 |
|
| 2015 |
Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha D, Hiroko M, Harismendy O, Becher O, Kwon C, Ligon KL, Saya H, Carter BS, Pizzo D, et al. Abstract PR13: Epigenetic regulation of MYC drives dynamic transition between tumor initiating states in glioblastoma Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-Pr13 |
0.383 |
|
| 2015 |
Li J, Kozono D, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, et al. Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression Cancer Research. 75: 979-979. DOI: 10.1158/1538-7445.Am2015-979 |
0.383 |
|
| 2015 |
Kozono D, Li J, Sampetrean O, Gonda D, Kushwaha D, Merzon D, Nitta M, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, et al. EPIG-02DYNAMIC EPIGENETIC MODULATION OF GLIOBLASTOMA TUMORIGENICITY BY INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) Neuro-Oncology. 17: v86.2-v86. DOI: 10.1093/Neuonc/Nov214.02 |
0.367 |
|
| 2014 |
Cheng CP, Kuo IY, Alakus H, Frazer KA, Harismendy O, Wang YC, Tseng VS. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression. Bioinformatics (Oxford, England). 30: 3054-61. PMID 25015989 DOI: 10.1093/Bioinformatics/Btu433 |
0.334 |
|
| 2014 |
Alakus H, Bollschweiler E, Hölscher AH, Warnecke-Eberz U, Frazer KA, Harismendy O, Lowy AM, Mönig SP, Eberz PM, Maus M, Drebber U, Siffert W, Metzger R. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy. Annals of Surgical Oncology. 21: 4375-82. PMID 24986238 DOI: 10.1245/S10434-014-3843-Y |
0.319 |
|
| 2014 |
Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O. Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin. Genome Medicine. 6: 43. PMID 24944587 DOI: 10.1186/Gm559 |
0.388 |
|
| 2014 |
Alakus H, Babicky M, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels M, Mose E, Peterson M, Lowy A, Frazer K, Harismendy O. Abstract 5191: Genome-wide mutational analysis reveals core signaling pathways in mucinous neoplasms of the appendix Cancer Research. 74: 5191-5191. DOI: 10.1158/1538-7445.Am2014-5191 |
0.416 |
|
| 2014 |
Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Gonda D, Kushwaha D, Vandenberg S, Ramakrishnan V, Zhu S, Furnari F, Matsui H, Harismendy O, Cavenee W, Mao Y, et al. CB-04 * EPIGENETIC REGULATION OF GLIOBLASTOMA TUMORIGENICITY: A HYBRID MODEL Neuro-Oncology. 16: v41-v41. DOI: 10.1093/Neuonc/Nou241.4 |
0.37 |
|
| 2013 |
Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. Evaluation of ultra-deep targeted sequencing for personalized breast cancer care. Breast Cancer Research : Bcr. 15: R115. PMID 24326041 DOI: 10.1186/Bcr3584 |
0.394 |
|
| 2013 |
DeBoever C, Reid EG, Smith EN, Wang X, Dumaop W, Harismendy O, Carson D, Richman D, Masliah E, Frazer KA. Whole transcriptome sequencing enables discovery and analysis of viruses in archived primary central nervous system lymphomas. Plos One. 8: e73956. PMID 24023918 DOI: 10.1371/Journal.Pone.0073956 |
0.347 |
|
| 2013 |
Yost SE, Alakus H, Matsui H, Schwab RB, Jepsen K, Frazer KA, Harismendy O. Mutascope: sensitive detection of somatic mutations from deep amplicon sequencing. Bioinformatics (Oxford, England). 29: 1908-9. PMID 23712659 DOI: 10.1093/Bioinformatics/Btt305 |
0.382 |
|
| 2013 |
Barrett CL, Schwab RB, Jung H, Crain B, Goff DJ, Jamieson CH, Thistlethwaite PA, Harismendy O, Carson DA, Frazer KA. Transcriptome sequencing of tumor subpopulations reveals a spectrum of therapeutic options for squamous cell lung cancer. Plos One. 8: e58714. PMID 23527012 DOI: 10.1371/Journal.Pone.0058714 |
0.352 |
|
| 2013 |
Yost SE, Pastorino S, Rozenzhak S, Smith EN, Chao YS, Jiang P, Kesari S, Frazer KA, Harismendy O. High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models. Plos One. 8: e56185. PMID 23441165 DOI: 10.1371/Journal.Pone.0056185 |
0.407 |
|
| 2013 |
Adema V, Mallo M, Arenillas L, Díez-Campelo M, Luño E, Palomo L, Perez-Ladaga A, Yost S, Cheng C, Harismendy O, Zamora L, Xicoy B, Pedro C, Cañizo C, Sanzo C, et al. Whole-Exome Sequencing In Myelodysplastic Syndromes With 5q- and Normal Karyotype Blood. 122: 1551-1551. DOI: 10.1182/Blood.V122.21.1551.1551 |
0.369 |
|
| 2013 |
Balaian L, Burkart M, Yost S, Rozenhak S, Ball ED, Frazer K, Harismendy O, Jamieson C. Abstract 219: Splicing inhibitors reduce human AML CD34+ cell survival and self-renewal during MDS/AML evolution in a leukemia stem cell supportive niche assay. Cancer Research. 73: 219-219. DOI: 10.1158/1538-7445.Am2013-219 |
0.33 |
|
| 2012 |
Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O, Frazer KA. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Research. 40: e107. PMID 22492626 DOI: 10.1093/Nar/Gks299 |
0.401 |
|
| 2012 |
Yost S, Alakus H, Matsui H, Jepsen K, Schwab R, Frazer K, Harismendy O. MutaScope: a high-sensitivity variant caller dedicated to high-throughput PCR amplicons sequencing Bmc Proceedings. 6: 1-1. DOI: 10.1186/1753-6561-6-S6-O22 |
0.378 |
|
| 2012 |
Ghia EM, Smith E, DeBoever C, Rassenti LZ, Rozenzhak S, Shepard P, Alakus H, Harismendy O, Barrett CL, Frazer KA, Kipps TJ. Genomic Analysis of Serial Chronic Lymphocytic Leukemia Samples Suggests That Epigenetic Changes, Rather Than Clonal Evolution, May Drive the Progression of This Leukemia Blood. 120: 4563-4563. DOI: 10.1182/Blood.V120.21.4563.4563 |
0.377 |
|
| 2012 |
Schwab R, Bao L, Pu M, Crain B, Dai Y, Nazareth L, Matsui H, Wallace A, Hasteh F, Harismendy O, Frazer K, Parker B, Messer K. Abstract P2-06-01: Breast-to-breast metastasis can cause hormone-receptor positive/triple negative bilateral synchronous tumors Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-06-01 |
0.389 |
|
| 2011 |
Harismendy O, Schwab RB, Bao L, Olson J, Rozenzhak S, Kotsopoulos SK, Pond S, Crain B, Chee MS, Messer K, Link DR, Frazer KA. Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing. Genome Biology. 12: R124. PMID 22185227 DOI: 10.1186/Gb-2011-12-12-R124 |
0.378 |
|
| 2011 |
Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, Frazer KA. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature. 470: 264-8. PMID 21307941 DOI: 10.1038/Nature09753 |
0.34 |
|
| 2011 |
Harismendy O, Kotsopoulos S, Bao L, Amorese D, Stapleton M, Olson J, Nakano M, Cairn B, Pond S, Messer K, Chen P, Sementchenko V, Schwab R, Chee M, Link D, et al. Abstract 4826: Identification of low prevalence somatic mutations in heterogeneous tumor samples Cancer Research. 71: 4826-4826. DOI: 10.1158/1538-7445.Am2011-4826 |
0.384 |
|
| 2010 |
Harismendy O, Bansal V, Bhatia G, Nakano M, Scott M, Wang X, Dib C, Turlotte E, Sipe JC, Murray SS, Deleuze JF, Bafna V, Topol EJ, Frazer KA. Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level. Genome Biology. 11: R118. PMID 21118518 DOI: 10.1186/Gb-2010-11-11-R118 |
0.344 |
|
| 2010 |
Bhatia G, Bansal V, Harismendy O, Schork NJ, Topol EJ, Frazer K, Bafna V. A covering method for detecting genetic associations between rare variants and common phenotypes. Plos Computational Biology. 6: e1000954. PMID 20976246 DOI: 10.1371/Journal.Pcbi.1000954 |
0.352 |
|
| 2010 |
Bansal V, Harismendy O, Tewhey R, Murray SS, Schork NJ, Topol EJ, Frazer KA. Accurate detection and genotyping of SNPs utilizing population sequencing data. Genome Research. 20: 537-45. PMID 20150320 DOI: 10.1101/Gr.100040.109 |
0.316 |
|
| 2009 |
Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH, Kotsopoulos SK, Samuels ML, Hutchison JB, Larson JW, Topol EJ, Weiner MP, Harismendy O, Olson J, Link DR, et al. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nature Biotechnology. 27: 1025-31. PMID 19881494 DOI: 10.1038/Nbt.1583 |
0.344 |
|
| 2009 |
Tewhey R, Nakano M, Wang X, Pabón-Peña C, Novak B, Giuffre A, Lin E, Happe S, Roberts DN, LeProust EM, Topol EJ, Harismendy O, Frazer KA. Enrichment of sequencing targets from the human genome by solution hybridization. Genome Biology. 10: R116. PMID 19835619 DOI: 10.1186/Gb-2009-10-10-R116 |
0.324 |
|
| 2009 |
Harismendy O, Frazer KA. Elucidating the role of 8q24 in colorectal cancer. Nature Genetics. 41: 868-9. PMID 19639026 DOI: 10.1038/Ng0809-868 |
0.332 |
|
| 2009 |
Harismendy O, Ng PC, Strausberg RL, Wang X, Stockwell TB, Beeson KY, Schork NJ, Murray SS, Topol EJ, Levy S, Frazer KA. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biology. 10: R32. PMID 19327155 DOI: 10.1186/Gb-2009-10-3-R32 |
0.319 |
|
| 2009 |
Harismendy O, Frazer K. Method for improving sequence coverage uniformity of targeted genomic intervals amplified by LR-PCR using Illumina GA sequencing-by-synthesis technology. Biotechniques. 46: 229-31. PMID 19317667 DOI: 10.2144/000113082 |
0.309 |
|
| 2006 |
Guffanti E, Percudani R, Harismendy O, Soutourina J, Werner M, Iacovella MG, Negri R, Dieci G. Nucleosome depletion activates poised RNA polymerase III at unconventional transcription sites in Saccharomyces cerevisiae. The Journal of Biological Chemistry. 281: 29155-64. PMID 16816405 DOI: 10.1074/Jbc.M600387200 |
0.348 |
|
| 2006 |
Guffanti E, Ferrari R, Preti M, Forloni M, Harismendy O, Lefebvre O, Dieci G. A minimal promoter for TFIIIC-dependent in vitro transcription of snoRNA and tRNA genes by RNA polymerase III. The Journal of Biological Chemistry. 281: 23945-57. PMID 16787917 DOI: 10.1074/Jbc.M513814200 |
0.321 |
|
| 2006 |
Oficjalska-Pham D, Harismendy O, Smagowicz WJ, Gonzalez de Peredo A, Boguta M, Sentenac A, Lefebvre O. General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1. Molecular Cell. 22: 623-32. PMID 16762835 DOI: 10.1016/J.Molcel.2006.04.008 |
0.567 |
|
| 2003 |
Harismendy O, Gendrel CG, Soularue P, Gidrol X, Sentenac A, Werner M, Lefebvre O. Genome-wide location of yeast RNA polymerase III transcription machinery. The Embo Journal. 22: 4738-47. PMID 12970186 DOI: 10.1093/Emboj/Cdg466 |
0.558 |
|
| Show low-probability matches. |